| Trial ID: | L6129 |
| Source ID: | NCT00842075
|
| Associated Drug: |
Pramlintide
|
| Title: |
Pramlintide in Adolescents With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00842075/results
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: pramlintide
|
| Outcome Measures: |
Primary: HbA1c Value After 28 Days, HbA1c values 28 days after randomization, 28 | Secondary: Weight Change After 28 Days Intervention Period, Mean weight change after 28 days intervention period, 28 days
|
| Sponsor/Collaborators: |
Sponsor: University of Colorado, Denver | Collaborators: Amylin Pharmaceuticals, LLC.
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
|
| Start Date: |
2006-12
|
| Completion Date: |
2009-12
|
| Results First Posted: |
2012-10-19
|
| Last Update Posted: |
2015-06-23
|
| Locations: |
Barbara Davis Center, Aurora, Colorado, 80010, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00842075
|
